{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:56:02Z","timestamp":1788998162247,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bioorg.2021.105422","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T02:40:43Z","timestamp":1634092843000},"page":"105422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituents"],"prefix":"10.1016","volume":"117","author":[{"given":"Dina","family":"Aboushady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari S.","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebaa M.","family":"El-Hossary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf H.","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105422_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4161\/viru.22507","article-title":"New antibiotic agents in the pipeline and how they can help overcome microbial resistance","volume":"4","author":"Gould","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.bioorg.2021.105422_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bioorg.2021.105422_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jgar.2018.11.019","article-title":"Epidemiology of antimicrobial resistance in Lebanese extra-hospital settings: An overview","volume":"17","author":"Osman","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bioorg.2021.105422_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and Evolution of Antibiotic Resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bioorg.2021.105422_b0025","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1002\/anie.201506818","article-title":"Targeting Antibiotic Resistance","volume":"55","author":"Chellat","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2021.105422_b0030","doi-asserted-by":"crossref","first-page":"e01510","DOI":"10.1128\/AAC.01510-17","article-title":"A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase","volume":"62","author":"El-Hossary","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105422_b0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2021.105422_b0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert. Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.bioorg.2021.105422_b0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.21307\/pjm-2018-043","article-title":"Emergence of High-level Gentamicin Resistance among Enterococci Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working","volume":"67","author":"Labibzadeh","year":"2018","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.bioorg.2021.105422_b0050","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2021.105422_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2021.105422_b0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1592\/phco.27.2.227","article-title":"Emerging Options for Treatment of Invasive, Multidrug-Resistant Staphylococcus aureus Infections","volume":"27","author":"Drew","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bioorg.2021.105422_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2021.105422_b0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.bioorg.2021.105422_b0075","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1248\/bpb.26.1711","article-title":"Synthesis, Analgesic, Anti-inflammatory and Antibacterial Activities of Some Novel 2-Methyl-3-substituted Quinazolin-4-(3H)-ones","volume":"26","author":"Alagarsamy","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2021.105422_b0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/13543776.2015.1039512","article-title":"Quinazoline derivatives as anticancer drugs: a patent review (2011 \u2013 present)","volume":"25","author":"Ravez","year":"2015","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2021.105422_b0085","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.bmcl.2004.07.065","article-title":"Synthesis and biological activity of novel antibacterial quinazolines, Bioorganic Med","volume":"14","author":"Bedi","year":"2004","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105422_b0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm401204g","article-title":"Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines","volume":"57","author":"Lam","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105422_b0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2015.03.014","article-title":"Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase","volume":"94","author":"Lu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105422_b0100","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.bmcl.2013.06.048","article-title":"Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines, Bioorganic Med","volume":"23","author":"Parhi","year":"2013","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105422_b0105","doi-asserted-by":"crossref","first-page":"e00059","DOI":"10.1128\/AAC.00059-17","article-title":"Characterizing the Antimicrobial Activity of N2, N4-Disubstituted Quinazoline-2,4-Diamines toward Multidrug-Resistant Acinetobacter baumannii","volume":"61","author":"Fleeman","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105422_b0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/jm00163a067","article-title":"Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines","volume":"33","author":"Harris","year":"1990","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105422_b0115","doi-asserted-by":"crossref","first-page":"e02637","DOI":"10.1128\/AAC.02637-18","article-title":"The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus","volume":"63","author":"Janardhanan","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105422_b0120","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/jm500039e","article-title":"Antibacterial Activity of a Series of N2, N4-Disubstituted Quinazoline-2,4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105422_b0125","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jm5000408","article-title":"Antileishmanial Activity of a Series of N2, N4-Disubstituted Quinazoline-2,4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:24:48Z","timestamp":1758615888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821007999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"alternative-id":["S0045206821007999"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105422","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Optimization of the 2,4-substituents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105422"}}